Not everything in the brain is meant to last. As our brains assemble, trillions of neural connections have to be built or torn down at the right time and place. Otherwise, the seeds of disorders like autism can take root. Cold Spring Harbor Laboratory Assistant Professor Gabrielle Pouchelon studies how the brain is wired early in life. In doing so, she hopes to find the origins of various brain dysfunctions and new ways to treat them. In a new study, Pouchelon and her team zero in o

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.

Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it has surpassed 90% of the enrollment target for pediatric patients at burn centers for its 2024 pivotal study designed to validate the AI-driven algorithm used by its DeepView™ System for its burn indication. “We are excited w

Medical robotics innovator Noah Medical today announced the final results from its FRONTIER Study, the platform’s first-in-human clinical trial testing the “Tool-in-Lesion” accuracy of its Galaxy System™, are now available for review in the Official Journal of the Asian Pacific Society of Respirology. The study found that the robotic platform’s TiLT+ Technology™ achieves 100% successful navigation to small lesions in the periphery, 89.5 (strict) to 94.7% (i

Stratasys Ltd. (NASDAQ: SSYS) and Ricoh USA, Inc. today announced the enrollment of the first patient in a groundbreaking clinical study aimed to evaluate the use of 3D printed models for orthopedic oncology. The study will assess the efficacy of patient-specific 3D printed anatomical models for preoperative planning and tumor excision in comparison to the current standard of care, which relies solely on CT or MRI imaging. The joint research aims to demonstrate potential improvement

AgileMD, Inc., an AI-powered clinical decision support company, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) marketing clearance for its eCART Clinical Deterioration Suite. eCART is a research-based, AI-driven software as a medical device (SaMD) that utilizes a machine learning algorithm to continuously assess hospitalized patients’ risk of impending death or intensive care unit (ICU) transfer, assisting medical staff in swift and accurate recognit

ShiftMed, a leader in On Demand workforce technology, has partnered with Luminis Health, a nationally recognized nonprofit health system in Maryland, to strengthen internal workforce capabilities. The partnership will provide resources to support Luminis Health in enhancing retention and filling positions for registered nurses. ShiftMed's application and network will support internal float pool capabilities enabling Luminis Health to quickly fill open positions and address unexp

Simplify Healthcare, a leading provider of enterprise SaaS solutions to Payers (health insurance companies), today announced the acquisition of Virtical.ai, a pioneering Artificial Intelligence (AI) company. This strategic move strengthens Simplify Healthcare's commitment to empowering its Payer customers with cutting-edge AI technology and reinforces its position at the forefront of the AI revolution. The acquisition will provide significant benefits to both companies' cust

Ronovo Surgical, a Shanghai-based medical technology innovator developing novel surgical robotics for soft tissue procedures, announces the successful closing of its Series B financing, raising a total of $44M million from leading healthcare technology investors to accelerate the commercialization of its proprietary modular robotic system, the Carina™ Platform, in the Chinese market and set the stage for international expansion. This round was co-led by Guolian

SOPHiA GENETICS, a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced its new Residual Acute Myeloid (RAM) Application. The new offering expands the company's comprehensive oncology portfolio to support measurable residual disease (MRD) capabilities and will be available to customers worldwide this summer. Acute Myeloid Leukemia (AML) represents about one percent of all cancers worldwide, yet is one of the most commo